Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ru Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Ru-Zr catalytic method for diaryl phosphate esters. High purity pharmaceutical intermediates with reduced costs and scalable supply chain solutions for global buyers.
Patent CN104059009A reveals asymmetric ruthenium catalysis for Ezetimibe intermediate ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Novel graphene-supported ruthenium catalyst method ensures high purity and selectivity for polymer and specialty chemical manufacturing supply chains.
Novel synthesis route for high-purity naphthamide intermediates offering cost reduction and supply chain reliability for pharmaceutical applications.
Patent CN105111125B details a high-yield synthesis route for fused heterocyclic ketones. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel ruthenium complex synthesis patent CN105440085A offers high purity and selectivity for antitumor drug manufacturing supply chain efficiency.
Patent CN105085189A details a robust aprotic solvent method for chiral alcohol synthesis, offering significant supply chain stability and cost reduction for pharmaceutical intermediates.
Efficient asymmetric Michael addition for pharmaceutical intermediates using novel Ru-diamine complexes. Reduces cost and improves purity for API manufacturing.
Patent CN101891746B details a novel rhodium-free route for meropenem. Discover cost-effective, high-purity carbapenem manufacturing solutions for your supply chain.
Patent CN111170829B details a safer, high-selectivity route for hexamethylindanol using supported Ru catalysts, offering significant cost and safety advantages for fragrance manufacturers.
Patent CN1360574A details a novel route for tricyclic aminoalcohol derivatives featuring asymmetric reduction. This process offers significant cost reduction and improved supply chain reliability for pharmaceutical manufacturing.
Novel metal-catalyzed synthesis offers mild conditions and high yields for phenyl pyrrolidine intermediates, ensuring supply chain stability and cost efficiency.
Patent CN107892698B details a solvent-free ruthenium catalyzed selective borylation method offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN106349295B reveals mild ruthenium catalysis for nitrobenzene reduction offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN101941900A reveals a novel Ru-catalyzed asymmetric hydrogenation route for high-purity chiral acids, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Patent CN105622363B enables one-step vanillyl alcohol ether production. Dual catalyst system ensures high purity and supply chain stability for global buyers.
Patent CN110922427A reveals TMSOTf-catalyzed route for sterically hindered phosphonites. Green, solvent-free process offers cost reduction in pharma intermediate manufacturing.
Novel catalytic method for imidazolone compounds ensures high yield and purity. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Patent CN117535268A reveals high-purity esterase resolution. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.